South Carolina biologics regulations.

Who may administer PRP, exosomes and stem cells in South Carolina, and which agencies to check.

A physician at a desk reading regulatory documents

Who may administer biologics in South Carolina?

In South Carolina, licensed medical doctors (MDs), doctors of osteopathy (DOs), and other practitioners under physician supervision qualify to administer biologic treatments, including stem cell therapy.

Official sources

South Carolina compliance guide.

FDA Compliance

Clinics must adhere to the FDA's guidelines for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). Specifically, providers should understand the requirements under 21 CFR Part 1271, which outline registration, screening, and testing for safety and efficacy.

South Carolina State Regulations

To comply with South Carolina-specific regulations, clinics should refer to the South Carolina Department of Health and Environmental Control (DHEC) for current guidelines regarding biologics and advanced therapies. South Carolina may have unique protocols for clinical oversight or operational standards; thus, staying updated with these is crucial for compliance.

Provider Qualifications

In South Carolina, licensed medical doctors (MDs), doctors of osteopathy (DOs), and other practitioners under physician supervision qualify to administer biologic treatments, including stem cell therapy. For more details on specific licensure requirements, visit the South Carolina Board of Medical Examiners page.

Patient Informed Consent

Ensuring that patients provide informed consent is essential. Providers should clearly explain the benefits, potential risks, and experimental nature of stem cell treatments. South Carolina clinics should prepare consent forms that highlight:

  • The nature of the biologic therapy
  • Potential risks and side effects
  • Alternative treatment options
  • Disclaimers on experimental status if applicable

Pre-Treatment and Post-Treatment Protocols

Establishing clear pre-treatment and post-treatment protocols is recommended to ensure patient safety and adherence to best practices. This includes thorough patient screening, proper documentation, and follow-up care to monitor patient response.

Standard Operating Procedures (SOPs)

Clinics should implement SOPs for the collection, processing, storage, and administration of biologics. SOPs help standardize care, enhance safety, and maintain compliance with both state and federal regulations.

Medical Liability Insurance

Obtaining medical liability insurance is strongly advised to protect the clinic against potential malpractice claims. Verify that your insurance policy covers the specific scope of services offered in biologic therapy.

Marketing Compliance

All marketing materials should adhere to truthful advertising standards, avoiding any misleading claims. Ensure that any promotional content complies with both FDA advertising guidelines and South Carolina’s specific advertising regulations for medical services.

This guide is a general summary to help clinics understand compliance requirements for biologics in South Carolina. It is not legal advice. Regulations change; consult legal counsel and the agencies above before acting on it.

South Carolina: common questions.

Who can administer stem cells, PRP and exosomes in South Carolina?
In South Carolina, licensed medical doctors (MDs), doctors of osteopathy (DOs), and other practitioners under physician supervision qualify to administer biologic treatments, including stem cell therapy. This is a general summary, not legal advice. Confirm with the state board.
Are stem cell and exosome therapies FDA-approved in South Carolina?
FDA rules are federal, so they apply in South Carolina as everywhere else. Exosome and stem cell therapies are not FDA-approved for therapeutic use, and PRP applications are considered off-label.
Do I need an IRB-approved study to offer biologics in South Carolina?
Investigational treatment belongs inside a reviewed study with proper informed consent. IRB review is not FDA authorisation: culture-expanded and other more-than-minimally-manipulated cell products generally need an IND before use in people.
How do I start offering biologics in South Carolina?
Start with the live webinar, then a discovery call and live training. After that we verify your South Carolina licence, protocol, product sourcing, consent process and advertising before you are listed for patient inquiries.

Practising in South Carolina? Start with the webinar.

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.